Literature DB >> 282780

Interferon therapy in neoplastic disease. A preliminary report.

I S Christophersen, R Jordal, K Osther, J Lindenberg, P H Pedersen, K Berg.   

Abstract

The treatment of 10 patients having neoplastic disease with exogenous i.m. interferon therapy is described. The interferon given is partially purified interferon produced from human leukocytes. Sendai virus is used as interferon inductor. The patients reported in this paper have been on treatment for periods of 2-28 months. Apart from initial periods of fever, no side-effects have been recorded. Patients suffering from bladder papillomas have shown partial regression after a few months of therapy. The other cases treated are too few to warrant any conclusions, but the therapy does seem to have been beneficial.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 282780     DOI: 10.1111/j.0954-6820.1978.tb08475.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  2 in total

1.  Approaches to the treatment of bladder cancer at Stanford.

Authors:  F M Torti
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 2.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.